June 13, 2025

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 65.73% Potential Upside in the Medical Devices Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a dynamic player in the healthcare sector, specializes in revolutionary medical devices aimed at addressing orthopedic challenges. With a market..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 35.5% Potential Upside in Healthcare

InnovAge Holding Corp. (NASDAQ: INNV) presents an intriguing opportunity for investors looking to tap into the healthcare sector, specifically within the niche of medical care facilities..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 289% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a notable potential upside of 289.14%, according to analyst..

Sionna Therapeutics, Inc. (SION) Stock Analysis: A Potential 126.60% Upside in the Biotech Sector

Sionna Therapeutics, Inc. (NASDAQ: SION) is drawing significant attention in the biotechnology sector, particularly for investors looking to capitalize on the burgeoning field of cystic fibrosis..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring Its 2.81% Upside Potential in the Healthcare Sector

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector specializing in home health and hospice services, has been drawing the attention of investors amid..

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator with a 126.91% Upside Potential

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is gaining significant attention in the healthcare sector due to its innovative approach to cancer treatment. With a..

Capricor Therapeutics, Inc. (CAPR): Investor Outlook Reveals a Compelling 202% Upside Potential

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is gaining attention in the healthcare sector with its innovative approach to treating diseases with high unmet..

Personalis, Inc. (PSNL) Stock Analysis: Unpacking the 20% Upside Potential

Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $513.17 million, this..

REGENXBIO Inc. (RGNX) Stock Analysis: Biotechnology Innovator with 211% Upside Potential

REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company, has piqued investor interest with its promising pipeline and remarkable potential upside. With a market capitalization of $511.64..

Septerna, Inc. (SEPN) Stock Analysis: Navigating a 127% Upside Potential in Biotechnology

Septerna, Inc. (NASDAQ: SEPN) stands out in the biotechnology sector with an intriguing investment profile, underscored by a potential upside of 127.35% according to the average..

MeiraGTx Holdings plc (MGTX) Investor Outlook: Potential 317% Upside in the Biotech Sphere

MeiraGTx Holdings plc (NASDAQ: MGTX) offers a compelling opportunity for investors seeking exposure to the burgeoning field of genetic medicine. Specializing in the development of transformative..

COMPASS Pathways Plc (CMPS) Investor Outlook: Riding the Wave of a 272% Potential Upside

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology firm focused on mental health, is making waves in the healthcare sector. With a market capitalization of $422.9..

KalVista Pharmaceuticals (KALV) Investor Outlook: Exploring a 102% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a dynamic player in the biotechnology sector, is capturing significant attention from investors, particularly with its potential upside of over 102%...

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a 202% Potential Upside in the Biotech Sector

Bicycle Therapeutics plc (NASDAQ: BCYC), a UK-based biotechnology firm, is capturing investor attention with a compelling potential upside of 202.33%. This clinical-stage pharmaceutical company is pioneering..

Verve Therapeutics, Inc. (VERV) Stock Analysis: Exploring a Potential 285% Upside

Verve Therapeutics, Inc. (NASDAQ: VERV) is capturing the attention of investors with its bold forays into the landscape of gene editing, targeting cardiovascular diseases. As a..

SIGA Technologies Inc. (SIGA) Stock Analysis: A Niche Player with Robust Forward P/E and High ROE

SIGA Technologies Inc. (SIGA), a commercial-stage pharmaceutical company, is carving a niche within the healthcare sector, specifically targeting the health security market. Headquartered in New York,..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Unveiling a Promising 50% Upside Potential for Investors

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands as a noteworthy entity in the biotechnology industry, particularly for investors with a keen eye on the healthcare sector. With..

AnaptysBio, Inc. (ANAB) Stock Analysis: High Growth Potential with 81% Upside

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company based in San Diego, is capturing investor attention with its impressive growth potential in the healthcare sector. Specializing..

Semler Scientific, Inc. (SMLR) Stock Analysis: Navigating Challenges and Opportunities in the Healthcare Sector

Semler Scientific, Inc. (NASDAQ: SMLR), a pivotal player in the healthcare sector, operates within the medical devices industry, providing innovative technology solutions designed to enhance clinical..

Arvinas, Inc. (ARVN) Stock Analysis: Unpacking a 155.76% Potential Upside in Biotechnology

Arvinas, Inc. (NASDAQ: ARVN) is making waves in the biotechnology sector with its innovative approach to drug development, primarily focusing on the degradation of disease-causing proteins..

Search

Funds

June 13, 2025

Search

Funds

June 13, 2025

FTSE 100

Funds